Synopsys, Inc. $SNPS Stock Sold by Choreo LLC

Choreo LLC trimmed its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 25.5% in the third quarter, HoldingsChannel.com reports. The fund owned 6,219 shares of the semiconductor company’s stock after selling 2,133 shares during the quarter. Choreo LLC’s holdings in Synopsys were worth $2,705,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Synopsys during the second quarter valued at $7,228,099,000. Van ECK Associates Corp raised its stake in Synopsys by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock valued at $1,542,175,000 after purchasing an additional 569,687 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Synopsys by 40.7% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock valued at $1,377,174,000 after purchasing an additional 892,736 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in Synopsys by 11.2% in the 3rd quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock valued at $1,187,381,000 after purchasing an additional 274,586 shares during the last quarter. Finally, Amundi lifted its holdings in Synopsys by 3.6% in the 1st quarter. Amundi now owns 1,761,983 shares of the semiconductor company’s stock valued at $698,591,000 after purchasing an additional 61,077 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $467.61 on Friday. The company has a market cap of $89.61 billion, a P/E ratio of 82.62, a P/E/G ratio of 1.90 and a beta of 1.21. The business has a fifty day simple moving average of $437.48 and a 200-day simple moving average of $443.62. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The firm had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. During the same period in the prior year, the business posted $3.39 earnings per share. The firm’s revenue for the quarter was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities research analysts forecast that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys declared that its board has authorized a share buyback program on Monday, October 5th that authorizes the company to buy back $1 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Share buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Wall Street Analysts Forecast Growth

SNPS has been the topic of several analyst reports. UBS Group set a $570.00 price target on shares of Synopsys in a research note on Thursday, August 27th. Roth Capital upgraded shares of Synopsys to a “buy” rating in a report on Friday, September 25th. Robert W. Baird raised shares of Synopsys from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $558.00 to $560.00 in a research report on Thursday, August 27th. Morgan Stanley upped their price objective on shares of Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a research note on Tuesday, October 20th. Finally, Rosenblatt Securities raised their target price on shares of Synopsys from $575.00 to $620.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and an average price target of $575.00.

View Our Latest Research Report on SNPS

Insider Activity at Synopsys

In related news, insider Janet Lee sold 1,144 shares of the firm’s stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the sale, the insider directly owned 16,534 shares of the company’s stock, valued at approximately $8,308,665.68. This trade represents a 6.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Aart de Geus sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the completion of the sale, the insider directly owned 120,421 shares in the company, valued at $53,197,180.96. This represents a 17.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 117,163 shares of company stock worth $51,366,457. 0.56% of the stock is owned by insiders.

Synopsys Profile

(Free Report)

Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.

The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.

In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.